title: Role of nitric oxide in sepsis-associated pulmonary edema.
abstract: Transient pulmonary hypertension after inhibition of nitric oxide synthase (NOS) does not alter pulmonary reflection coefficients or lymph flows in endotoxemic sheep. To test the effects of persistent pulmonary hypertension induced by N omega-nitro-L-arginine methylester (L-NAME) and of inhaled NO on pulmonary edema, 18 sheep (three groups) were chronically instrumented with pulmonary artery catheters, femoral arterial fiberoptic thermistor catheters, and tracheostomy. The awake, spontaneously breathing animals received Salmonella typhi endotoxin (lipopolysaccharide; LPS) (10 ng/kg/ min) for 28 h. After 24 h, an airflow of 6 L/min was delivered through the tracheostomy. One group of animals (L-NAME/air) received L-NAME intravenously (25 mg/kg + 5 mg/kg/h) and breathed air. The second group (L-NAME/NO) was given L-NAME and NO (40 ppm) was added to the airflow. The third group was given NaCl 0.9% and breathed air (NaCl/air). Extravascular lung water was measured through the double-indicator dilution technique. Endotoxemia caused pulmonary edema, which was aggravated by L-NAME. Breathing of NO normalized pulmonary artery pressure (Ppa) and ameliorated pulmonary edema. Inhalation of NO may therefore be a therapeutic option for pulmonary edema associated with pulmonary hypertension.
authors.affiliation: Klinik und Poliklinik für Anästhesiologie und operative Intensivmedizin, Westfälische Wilhelms-Universität Münster, M unster, Germany.
authors.forename: F
authors.initials: F
authors.lastname: Hinder
authors.forename: H D
authors.initials: HD
authors.lastname: Stubbe
authors.forename: H
authors.initials: H
authors.lastname: Van Aken
authors.forename: R
authors.initials: R
authors.lastname: Waurick
authors.forename: M
authors.initials: M
authors.lastname: Booke
authors.forename: J
authors.initials: J
authors.lastname: Meyer
mesh_terms: D000280:Administration, Inhalation; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D019446:Endotoxemia / Q000150:complications; D004791:Enzyme Inhibitors / Q000494:pharmacology; D015633:Extravascular Lung Water / Q000378:metabolism; D005260:Female; D019331:NG-Nitroarginine Methyl Ester / Q000494:pharmacology; D009569:Nitric Oxide / Q000008:administration & dosage / Q000494:pharmacology / Q000502:physiology*; D011651:Pulmonary Artery / Q000503:physiopathology; D011654:Pulmonary Edema / Q000382:microbiology* / Q000503:physiopathology*; D012481:Salmonella Infections, Animal / Q000150:complications*; D012756:Sheep
chemical_list: D004791:Enzyme Inhibitors; D009569:Nitric Oxide; D019331:NG-Nitroarginine Methyl Ester